Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s ...
Dr Raminderpal Singh speaks with Dr Srijit Seal about why specialised AI agents are outperforming general-purpose models in ...
Pharmaceutical Technology on MSN
QIAGEN and NVIDIA partner on AI drug discovery
The integration helps researchers understand disease biology and uncover biomarkers for developing new medicines.
Many of the most exciting discoveries in science involve highly specialized knowledge and making connections between far-flung facts. Scientists must combine deep analysis with broad reasoning ...
By combining AI, simulations, and lab testing, researchers rapidly screened thousands of drugs and uncovered an unexpected ...
NEW YORK--(BUSINESS WIRE)--The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New York City, unveiling advances that mark a pivotal ...
With the help of artificial intelligence, a coalition of Bay Area institutions identified 18 FDA-approved drugs that could improve the lives of those suffering from amyotrophic lateral sclerosis, ...
AI scientists have improved leaps and bounds in the last few years but there are still some significant concerns and limitations.
Key factors driving this growth include the increasing need to lower drug development costs and timelines, the rising ...
Technology Networks spoke with Cenevo on how agentic AI is supporting modern labs by connecting fragmented systems, improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results